QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.

Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.

Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma,  modelling experts, and experienced project managers.

Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.

Press

30Jun 2025

From 1 September 2025, companies must notify the DMP (NOMA) three months in advance before submitting STA documentation

See what else will change below 👇

The DMP has published updated requirements for the single technology assessment (STA) submission process, applying to both reimbursement and hospital medicines, effective from 1 September 2025.

Key changes:
• 🗓 Companies must notify the DMP of their intended STA submission week at least three months in advance
• 👩‍⚕️ Earlier recruitment of medical experts will begin upon notification
• 📑 More formal and enforceable standards for the […]

26Jun 2025

Economic burden of narcolepsy: new study published

Quantify Research has co-authored a new paper on the health care and productivity costs of narcolepsy, using comprehensive Swedish registry data.
The study matched incident narcolepsy patients to controls by age and sex to isolate the disease burden.

The study’s findings included:
👉2–5x higher use of inpatient, outpatient, and pharmaceutical care
👉Significantly more days on sick leave and disability leave

The results point to a substantial economic […]

24Jun 2025

How can the Nordics unlock the full potential of their health data and strengthen cross-border collaboration?

Join us at the end of October in Helsinki or remote for an event hosted by VALO and the FinHITS project to explore what’s already been achieved—and what lies ahead.

Our own Emilie Toresson Grip (Quantify’s Head of RWE & Analytics) has been invited to share insights on leveraging secondary care data from Finland. With extensive experience in Nordic RWE research, Emilie will highlight how Finnish data performs in relation […]